Larimar Therapeutics (LRMR) Total Debt Growth (1y) (2015 - 2020)
Larimar Therapeutics (LRMR) Total Debt Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -50.12% |
| Dec 31, 2019 | -44.26% |
| Sep 30, 2019 | -50.41% |
| Jun 30, 2019 | -35.94% |
| Mar 31, 2019 | -32.91% |
| Dec 31, 2018 | -24.08% |
| Sep 30, 2016 | -71.17% |
| Jun 30, 2016 | -59.33% |
| Mar 31, 2016 | -50.68% |
| Dec 31, 2015 | -44.10% |
| Sep 30, 2015 | -38.96% |
| Jun 30, 2015 | -34.86% |